Average Co-Inventor Count = 3.96
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (37 from 3,685 patents)
2. Ortho Pharmaceutical Corporation (4 from 377 patents)
3. Other (3 from 832,880 patents)
4. E. R. Squibb Sons, Inc. (1 from 1,624 patents)
5. University of Pennsylvania (2,620 patents)
6. Astrazeneca Ab (1,500 patents)
45 patents:
1. 8614332 - Substituted pyrazolylamides useful as glucokinase activators
2. 8557841 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
3. RE44186 - Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
4. 8232291 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
5. 8153677 - Substituted pyrazolylamide compounds useful as glucokinase activators
6. 8143425 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
7. 8119808 - Tetrahydroquinoline derivatives as cannabinoid receptor modulators
8. 8030306 - Azabicyclic heterocycles as cannabinoid receptor modulators
9. 7977353 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
10. 7960349 - N-terminally modified GLP-1 receptor modulators
11. 7910601 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
12. 7884113 - Tetrahydroquinoline derivatives as cannabinoid receptor modulators
13. 7799801 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
14. 7592354 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
15. 7589102 - Heterocyclic aromatic compounds useful as growth hormone secretagogues